Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mateon Therapeutics Inc (NASDAQ:MATN)

0.72
Delayed Data
As of Jul 29
 +0.0099 / +1.39%
Today’s Change
0.49
Today|||52-Week Range
1.42
-5.25%
Year-to-Date
No recent news for Mateon Therapeutics Inc.

Today’s Trading

Previous close0.71
Today’s open0.73
Day’s range0.72 - 0.74
Volume69,372
Average volume (3 months)397,439
Market cap$19.1M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+28.00%
Earnings growth (this year)-64.81%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SNGXSoligenix Inc0.000.00%
WGBSWaferGen Bio-systems...+0.01+1.02%
BINDBIND Therapeutics In...-0.09-10.17%
CSBRChampions Oncology I...-0.04-2.00%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$13.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William D. Schwieterman
Chief Financial &
Accounting Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs